Previous 10 | Next 10 |
The Hague, February 16, 2022 - Aegon has taken note of the announcement issued today by Vienna Insurance Group AG Wiener Versicherung Gruppe (VIG) about the agreement reached between VIG and the Hungarian state holding Corvinus Nemzetközi Befektetési Zrt. (Corvinus) on the details...
No matter how long is the time you dedicate to look at/hold AbbVie, it's a "movie" with a happy ending, with a second-to-none acting performance. In spite of near-future growth concerns, and even if the stock might be (technically/optically) looking fully valued, we believe that there...
Please click here to access all 4Q2021 results related documents The Hague, February 9, 2022 - Solid progress against strategic and financial objectives Net result doubles compared with the fourth quarter of 2020 to EUR 526 million. Full-year 202...
The Hague, February 2, 2022 - Aegon announced today that Deborah Waters (54, American) will be appointed as Chief Technology Officer (CTO) and member of the Management Board of Aegon N.V. effective February 7, 2022. Deborah Waters joins Aegon from Citigroup Inc., where she held variou...
The Hague, January 25, 2022 - Aegon has completed the share buyback program announced on January 7, 2022, in relation to its obligations resulting from the 2021 and 2022 share-based compensation plans for senior management. The repurchased shares will be held as treasury shares until ...
The Hague, January 7, 2022 - Aegon announced today that it will repurchase common shares for an amount of EUR 50 million to meet its obligations resulting from the 2021 and 2022 share-based compensation plans for senior management. The repurchased shares will be held as treasury shares unti...
The Hague, December 22, 2021 - Aegon has taken note of an announcement issued today by Vienna Insurance Group AG Wiener Versicherung Gruppe (VIG). The announcement issued by VIG reads as follows: “Vienna Insurance Group and Hungary reach an agreement on the outlines of a ...
The Hague, December 15, 2021 - Aegon today announces that it has reinsured an additional part of its longevity exposure in the Netherlands with Reinsurance Group of America, Incorporated (RGA). This transaction improves the risk profile of the Dutch Life business and releases capital a...
The Hague, November 30, 2021 - Aegon announced today that Astrid Jäkel (44, German) will be appointed as Chief Risk Officer (CRO) and member of the Management Board of Aegon N.V. effective March 1, 2022. Her responsibilities will include managing Aegon’s Group Risk and Actuarial...
Please click here to access all 3Q2021 results related documents The Hague, November 11, 2021 - C onsistent execut ion on strategic initiatives ; results impacted by adverse mortality experience Net loss of EUR 60 million reflects a EUR 470 m...
News, Short Squeeze, Breakout and More Instantly...
2024-03-27 17:08:02 ET About to begin a phase 2b/3 multinational study of Ifenprodil Algernon Pharmaceuticals is a drug repurposing company. They're a phase 2 clinical stage company advancing a drug called Ifenprodil for idiopathic pulmonary fibrosis, but also as a potential thera...
2024-03-27 17:08:02 ET A stroke can be a devastating and debilitating event for an individual and their family, and a major burden on the health care system. Over 15 million people suffer strokes every year, and 85% of those have some form of disability as a result. Stroke-related cos...
2024-03-27 17:08:02 ET Stocks to Invest in: Healthcare Focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease Algernon is a drug re-purposing company that investigates safe, already approved drugs, inclu...